Archiwa News - Nanotechnologia w medycynie

NanoGroup’s PLN 11.9 million bioadsorber project moves to final stage of evaluation

NanoSanguis, a subsidiary of NanoGroup, has successfully passed the first stage of evaluation of the submitted grant application for the project “Spe…

NanoGroup unveils the first unit of the NanOX Recovery Box organ perfusion device. Innovative solution enters engineering testing stage and prepares for certification

NanoGroup S.A., a WSE-listed company developing innovative medical technologies, has unveiled the first unit of the NanOX Recovery Box organ perfusion devi…

$1.5 billion for OrganOx. A valuation that changes the rules of the game in transplantation

In August 2025, Terumo Corporation acquired UK-based OrganOx for $1.5 billion. This transaction set a new valuation standard for innovative medical co…

NanoGroup enters into investor agreements to secure financing for NanOX development process

On August 25 and 26, 2025, NanoGroup signed investor agreements for a total of 17 PLN million. Who has invested in NanoGroup? The Chairman of the…

NanoGroup team invests in the future – summary of incentive program

We have completed the implementation of the first stage of NanoGroup S.A.’s incentive program. The program covers the years 2023-2025 and is based on…

Conclusion of funding agreement for PLN 22.8 million for NanOX 4 Kidney project

NanoSanguis S.A., a NanoGroup company, has signed an agreement for funding from the European Funds for a Modern Economy (FENG) program in the amo…

Contact for media

Nina Żwirko

PR Contact

Media resources

Company logo

logotype.zip (1.27 MB )

Download

Media resources

Company logo

logotype.zip (1.27 MB)

Download